Ovid Therapeutics to Present at Jefferies 2015 Global Healthcare Conference

New York, NY – May 29, 2015 – (Business Wire) – Ovid Therapeutics Inc. (Ovid), a privately held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain, today announced that Dr. Jeremy Levin, Chairman and Chief Executive Officer, will present at the Jefferies 2015 Global Healthcare Conference at the Grand Hyatt Hotel on Monday, June 1, 2015 at 8:30a.m. Eastern Time in New York, NY.

About Ovid Therapeutics Inc.

Ovid Therapeutics Inc. is a privately-held, New York based, biopharmaceutical company committed to transforming the lives of patients with rare and orphan diseases of the brain and few, if any, treatment options – patients who currently have no hope of cure or improvement. Ovid focuses on patients and their needs. Using the significant operational, product development and business development experience of its management team, Ovid aims to become a leading neurology company, with multiple products and a rich pipeline, coupled with compelling research and development.

For more information on Ovid, please visit http://ovidrx.com.

 

CONTACTS:

Ovid Therapeutics Inc.
Dr. Anna Kazanchyan, 212-776-4381
SVP Product Development
akazanchyan@ovidrx.com

or

Burns McClellan, on behalf of Ovid Therapeutics
Justin Jackson, 212-213-0006, ext. 327
jjackson@burnsmc.com